@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix chebi: . @prefix RNA: . @prefix mgi: . @prefix geneProductOf: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: mgi:88137; a RNA: . sub:_2 occursIn: species:10090; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject chebi:24261; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:glucocorticoid) -> r(MGI:Bckdhb)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "1.4" . sub:_3 prov:value "acidification or glucocorticoids increase the maximal activity and subunit mRNA levels of branched chain alpha-ketoacid dehydrogenase [BCKAD] in various cell types dexamethasone concurrently stimulated E2 subunit promoter activity and reduced the binding of nuclear factor-kappaB to a site in the E2 promoter thus acidification and glucocorticoids independently enhance BCKAD subunit gene expression, and the glucocorticoid repsonse in the E2 subunit involves interference with NF-kappaB, which may act as a transrepressor"; prov:wasQuotedFrom pubmed:11287331 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:11287331; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:29:55.335+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }